Black Hawk Acquisition

BKHANasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$18.691 M

$4.50 -19.21%

Close of 6 Nov 2026

As of 6 Nov 2026, Black Hawk Acquisition (BKHA) has a market capitalization of $18.7M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

$1.33M

#2328 by earnings

Shares outstanding

4,153,577

Latest filing cover page

P/E ratio

14.1

Cap ÷ net income

Other share classes

Black Hawk Acquisition lists more than one class of stock. Company figures above cover all classes combined.

BKHAR BKHAU

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →

#137Cel SciCVM$24.6M
#138BioStem TechnologiesBSEM$19.4M
#139Black Hawk AcquisitionBKHA$18.7M
#140Estrella ImmunopharmaESLA$17.6M
#141PluriPLUR$17.1M

What if Black Hawk Acquisition were worth as much as…

Open the what-if tool →

Gold $28.2T

$6,798,206

Per share 1,510,713× higher

Bitcoin $1.53T

$367,839.11

Per share 81,742× higher

Apple $5.02T

$1,207,581

Per share 268,351× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for Black Hawk Acquisition are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.